Executive Director, Lifecycle Leader

Iovance Biotherapeutics aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapy for people with cancer. We are pioneering a transformational approach to treating cancer by harnessing the ability of the human immune system to recognize and attack diverse cancer cells in each patient. The Iovance TIL platform has demonstrated promising clinical data across multiple solid tumors. We are committed to continuous innovation in cell therapy, including gene-edited cell therapy, which may be a promising option for patients with cancer. Overview The Lifecycle leader (LCL) is responsible for shaping the program vision, strategic context, and...

Summary and match are AI-generated; verify details on the original posting.

Listed via Himalayas. All sources